REMEDY FOR HUMAN NERVE ECTODERMAL MALIGNANT TUMOR AND EPITHELIAL CANCER

Major tumor regression with only mild side-effects is observed by treatment of human melanoma patients with R24 mouse monoclonal antibody that identifies GD3 ganglioside on the surface of melanoma and other cells of neuroectodermal origin. R24 also serves to treat epithelial carcinomas as for exampl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ARAN ENU HOOTON, DEBITSUDO MINTSUAA, SHIDONII UERUTSU, ROIDO JIEI OURUDO, ERIZABESU KAAZUUERU, MAIRON AARU MERAMETSUDO, BETEIINA ERU FURIIGERU, SAROJI BADAN, HERUBERUTO EFU ETOGEN, KARUROSU KORUDON KARUDO
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Major tumor regression with only mild side-effects is observed by treatment of human melanoma patients with R24 mouse monoclonal antibody that identifies GD3 ganglioside on the surface of melanoma and other cells of neuroectodermal origin. R24 also serves to treat epithelial carcinomas as for example lung and/or breast tumor. Metasteses of the various cancers can also be treated.